Elucidata Corporation

Elucidata Corporation is a software company headquartered in San Francisco, California. The company employs over 120 individuals across the United States and India. With a revenue of $50 million, Elucidata focuses on developing innovative solutions for the life sciences industry. Elucidata's flagship product, Polly, is a data harmonization platform specifically designed for biomedical research. Polly transforms complex, multi-modal datasets from various sources, including omics, assay, real-world data, clinical records, and CRO data, into a unified data model. This process prepares the data for machine learning applications, accelerating time to analysis for research teams. Elucidata's platform is utilized by prominent biopharmaceutical companies like Pfizer, Janssen Pharmaceuticals, NextGen Jane, and IMBDx, as well as numerous research labs. One of Elucidata's key differentiators is its LLM-powered curation process, which achieves 99.99% accuracy while being 10 times faster than traditional methods. The platform also incorporates a human-in-the-loop model, ensuring quality control and data integrity. Elucidata's solutions empower scientists by reclaiming valuable time, allowing them to focus on driving scientific breakthroughs. For inquiries and to schedule a meeting, interested parties can reach out to Elucidata via email at [email protected]. Additional information about the company and its products is available on their website at www.elucidata.io/.